Received Mar 7, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | N77J2 | — |
Nurse explained that they administered just the diluent portion without reconstituting of a Shingrix vaccine to a patient; Nurse explained that they administered just the diluent portion without reconstituting of a Shingrix vaccine to a patient; Patient received first dose of Shingrix on March 6th 2024; This non-serious case was reported by a nurse via call center representative and described the occurrence of inappropriate preparation of medication in a 53-year-old female patient who received Herpes zoster (Shingrix) (batch number X5J23, expiry date 25-JAN-2026) and (batch number N77J2, expiry date 23-OCT-2026) for prophylaxis. Previously administered products included Shingrix (received 1st dose of shingrix on 06th March 2024). On 03-MAR-2025, the patient received the 2nd dose of Shingrix. On 03-MAR-2025, an unknown time after receiving Shingrix, the patient experienced inappropriate preparation of medication (Verbatim: Nurse explained that they administered just the diluent portion without reconstituting of a Shingrix vaccine to a patient), inappropriate dose of vaccine administered (Verbatim: Nurse explained that they administered just the diluent portion without reconstituting of a Shingrix vaccine to a patient) and drug dose administration interval too long (Verbatim: Patient received first dose of Shingrix on March 6th 2024). The outcome of the inappropriate preparation of medication, inappropriate dose of vaccine administered and drug dose administration interval too long were not applicable. Additional Information: GSK Receipt Date : 03-MAR-2025 Licensed Practical Nurse explained that they administered just the diluent portion without reconstituting of a Shingrix vaccine to a patient on March 3rd 2025 which led to Inappropriate preparation of medication and Inappropriate dose of vaccine administered. Patient received first dose of Shingrix on March 6th 2024. The patient received 2nd dose of Shingrix, later than the recommended interval, which led to lengthening of vaccination schedule.